Characterization and biological effects of recombinant human erythropoietin.

Abstract

Human recombinant erythropoietin (rHuEPO) has been purified to apparent homogeneity and compared to purified human urinary erythropoietin (EPO). Both the purified natural and recombinant EPO preparations were characterized in a competition radioimmunoassay (RIA), the exhypoxic polycythemic mouse bioassay, in vitro tissue culture bioassays using bone marrow cells, and by Western analysis. In the immunological and biological activity assays, the rHuEPO shows a dose response which parallels that of the natural hormone. By Western analysis, the recombinant and human urinary EPO migrate identically. Administration of rHuEPO increases the hematocrit of normal mice in a dose-dependent manner. Additionally, the rHuEPO is able to increase the hematocrit of rats made uremic as a result of subtotal nephrectomy. In summary, by all criteria examined, the rHuEPO is biologically active and equivalent to the natural hormone.

0200400600'91'94'97'00'03'06'09'12'15
Citations per Year

1,997 Citations

Semantic Scholar estimates that this publication has 1,997 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Egrie1986CharacterizationAB, title={Characterization and biological effects of recombinant human erythropoietin.}, author={Joan C Egrie and Tracy Strickland and John T. Lane and Kenneth H. Aoki and Aharon Mordechai Cohen and Rana L Smalling and Geri Trail and F . K . Lin and Jeffrey K Browne and Dustin Hines}, journal={Immunobiology}, year={1986}, volume={172 3-5}, pages={213-24} }